Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-16 Purchase | 2023-05-18 4:44 pm | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar President and Head of R&D | 5,000 | $0.68 | $3,400 | 34,226 (Direct) | View |
| 2022-02-02 Purchase | 2022-02-03 09:21 am | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director | 10,000 | $8.01 | $80,100 | 29,226 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-11 Option Award | 2024-06-13 4:08 pm | N/A 2034-06-11 | Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director | 34,400 | $0 | 34,400 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:42 pm | N/A 2034-01-02 | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar President and Head of R&D | 863,617 | $0 | 1,761,460 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 4:47 pm | N/A 2033-12-14 | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar President and Head of R&D | 334,005 | $0 | 334,005 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 9:19 pm | N/A 2033-06-06 | Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director | 9,650 | $0 | 9,650 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-04 4:51 pm | N/A 2032-12-30 | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar President and Head of R&D | 790,093 | $0 | 790,093 (Direct) | View |
| 2022-12-13 Option Award | 2022-12-15 6:07 pm | N/A 2032-12-13 | Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director | 9,650 | $0 | 9,650 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:39 pm | N/A 2032-06-17 | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director | 15,500 | $0 | 15,500 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 5:11 pm | N/A 2032-06-07 | Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director | 51,000 | $0 | 51,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 5:04 pm | N/A 2031-06-17 | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director | 15,500 | $0 | 15,500 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 4:00 pm | N/A 2031-06-16 | Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-09-28 Conversion | 2020-09-30 4:37 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director | 36,873 | $0 | 19,226 (Direct) | View |
| 2020-09-23 Option Award | 2020-09-25 5:12 pm | N/A 2030-09-23 | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director | 31,000 | $0 | 31,000 (Direct) | View |
Ownership | 2020-09-23 8:28 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director | 0 | $0 | 27,397 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 4:18 pm | N/A 2030-06-16 | Solid Biosciences Inc. | SLDB | Nagendran Sukumar Director | 40,000 | $0 | 40,000 (Direct) | View |